Emcure Pharma IPO: Emcure Pharmaceuticals’ IPO is about to open. Investors will be able to invest in it starting July 3. The company has also fixed the price band of this IPO. Through this IPO, Emcure is trying to raise Rs 1952.03 crore. Fresh shares worth Rs 800 crore are being issued.
At the same time, shares worth Rs 1152.03 crore have been issued through an IPO. If you are considering investing in this IPO, we are telling you how much the price band of the shares has been fixed.
Has The Company Fixed Such A Price Band?
Emcure Pharma has announced the price band of its shares. The price band of shares with a face value of Rs 10 has been fixed between Rs 960 and Rs 1008. The company has fixed a lot size of 14 shares. In such a situation, retail investors can bid on at least one lot, i.e. 14 shares and a maximum of 14 lots, i.e. 196 at a time. Retail investors can buy shares ranging from Rs 14,112 to Rs 1,97,568 in such a situation. The company’s shares will be listed on BSE and NSE. The company has reserved 50 per cent of the IPO for QIB. At the same time, 35 per cent has been reserved for retail investors and 15 per cent for NII.
Where Will The Company Use The Money
Kotak Mahindra Bank Capital Company Limited, JP Morgan India Private Limited, Jefferies India Private Limited, and Axis Capital Limited are its book-running lead managers for this IPO. The company will use Rs 600 crore to repay the loan raised through the IPO. As of March 2024, it had a debt of Rs 2,091.90 crore. At the same time, the remaining amount will be used for general corporate purposes.
How Is The Financial Condition Of The Company?
Emcure Pharma Company’s business is spread across Europe, Canada, and India. In 2024, the company earned 48.28 per cent of its earnings from India. The company’s profit decreased by 6% to Rs 527.60 crore. The company’s earnings increased by 11.2 per cent to Rs 6,658.30 crore during this period.
Know The Important Dates Related To IPO
Emcure’s IPO will open for investors between July 3 and 5. At the same time, shares will be allotted on July 8. Unsuccessful investors will receive a refund on July 9. Shares will be available in the demat account on July 9. The listing of shares will be done on July 10, 2024.
